The incidence of adverse adverse reactions is given in accordance with the WHO classification:
Often - more than 1 in 10 treated
Often - less than 1 in 10, but more than 1 in 100 treated
On occasion - less than 1 in 100, but more than 1 in 1,000 treated
Rarely - less than 1 in 1000, but more than 1 in 10,000 undergoing treatment
Rarely - less than 1 in 10,000, including individual cases
From the hemopoietic system and lymphatic system:
very rarely: spot hemorrhages in the mucous membranes, skin, thrombocytopenia, hemorrhagic rash (purpura), thrombophlebitis; thr From the immune system:
in some cases: systemic allergic reactions (up to the development of anaphylactic shock);
From the central nervous system:
very rarely: a change or a violation of taste;
very rarely: convulsions;
From the side of the organ of vision: very rarely: diplopia;
From the skin and subcutaneous tissue:
in some cases: allergic reactions - hives, itching, eczema, rash.
Other adverse reactions:
in some cases: in connection with the improvement of glucose assimilation, it is possible to reduce the concentration of glucose in the blood. This may cause symptoms of hypoglycemia - dizziness, increased sweating, headache, vision disorders; in some cases: allergic reactions at the injection site - irritation, flushing or swelling;
rarely: in case of rapid administration of the drug, an increase
intracranial pressure (there is a feeling of heaviness in the head), difficulty breathing. These reactions take place on their own.
- If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.